NEW YORK (GenomeWeb) – In Nature Genetics, an international team led by investigators at St. Jude Children's Research Hospital described variants in the ACYP2 gene that appear to notch up the risk of hearing loss in children treated with the anticancer drug cisplatin.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.